Search
for
Sort by
Research 61–90 of 1000+
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia
- The genetic basis of dermatophytosis skin infection susceptibility
- Geriatric Dermatologic Therapy
- Most Baricitinib Responders Achieved Full Scalp Hair Regrowth: Findings from Adult and Paediatric BRAVE-AA Trials
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- <i>DSG4</i> Gene Variants as a Cause of Hypotrichosis in the Child with Severe Atopic Dermatitis: Clinical Case
- Farmácia Militar do Laboratório Nacional do Medicamento, Porto e Serviços Farmacêuticos do Centro Hospitalar Universitário do Porto (Hospital de Santo António), EPE, Porto
- Discovering the potential of natural remedies in the post COVID-19 complications based on in silico techniques
- Patched-assoziierte Tumoren: Modifikatorgene und Pathogenese
- Les hormones sexuelles et la peau : questionnaire à l'attention des vétérinaires praticiens. Mise à jour bibliographique et synthèse
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- Stem Cell-Based Tissue Engineering for the Treatment of Burn Wounds: A Systematic Review of Preclinical Studies
- Cosmetics
- Sıçan Derisinde Vimentin, Desmin ve Laminin’in Dağılımı
- SARS-CoV-2 Infection and COVID-19 Vaccination Associated with Post-Acute Alopecia: Prevalence, Clinical Patterns, and Determinants Among Saudi Adults
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
- Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
- Evaluating the role of COVID-19 vaccines in the landscape of medication-induced alopecia areata
- A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative)
- Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Mucosal TLR5 activation controls healthspan and longevity